Methotrexate Co-Treatment Increases Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
A Randomized Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled GOut Receiving Pegloticase (MIRROR RCT): Primary Efficacy and Safety Findings
Arthritis Rheumatol 2022 Sep 13;[EPub Ahead of Print], JK Botson, K Saag, J Peterson, N Parikh, S Ong, D La, K LoCicero, K Obermeyer, Y Xin, J Chamberlain, B LaMoreaux, S Verma, S Sainati, S Grewal, A Majjhoo, JRP Tesser, ME WeinblattFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.